Skip to main content
Top
Published in: Journal of Endocrinological Investigation 2/2024

13-08-2023 | Erectile Dysfunction | Original Article

Investigating the prevalence of erectile dysfunction among men exposed to organophosphate insecticides

Authors: F. Glover, A. Mehta, M. Richardson, W. Muncey, F. Del Giudice, F. Belladelli, N. Seranio, M. L. Eisenberg

Published in: Journal of Endocrinological Investigation | Issue 2/2024

Login to get access

Introduction

Erectile dysfunction (ED) poses a significant disease morbidity and contributor to male infertility, where an estimated 20-40% of men are affected annually. While several risk factors have been identified in the etiology of ED (e.g., aging, heart disease, diabetes, and obesity), the complete pathogenesis remains to be elucidated. Over the last few decades, the contribution of environmental exposures to the pathogenesis of ED has gained some attention, though population studies are limited and results are mixed. Among environmental contaminants, organophosphate (OP) insecticides represent one of the largest chemical classes, and chlorpyrifos is the most commonly used OP in the U.S. OP exposure has been implicated in driving biological processes, including inflammation, reactive oxygen species production, and endocrine and metabolism disruption, which have been demonstrated to adversely affect the hypothalamus and testes and may contribute to ED. Currently, studies evaluating the association between OPs and ED within the U.S. general population are sparse.

Methods

Data were leveraged from the National Health and Nutrition Examination Survey (NHANES), which is an annually conducted, population-based cross-sectional study. Urinary levels of 3,5,6-trichloro-2-pyridinol (TCPy), a specific metabolite of the most pervasive OP insecticide chlorpyrifos, were quantified as measures of OP exposure. ED was defined by responses to questionnaire data, where individuals who replied “sometimes able” or “never able” to achieve an erection were classified as ED. Chi-square, analysis of variance (ANOVA), and multivariable, weighted linear and logistic regression analyses were used to compare sociodemographic variables between quartiles of TCPy exposure, identify risk factors for TCPy exposure and ED, and to analyze the relationship between TCPy and ED.

Results

A total of 671 adult men were included in final analyses, representing 28,949,379 adults after survey weighting. Approximately 37% of our cohort had ED. Smoking, diabetes, aging, Mexican–American self-identification, and physical inactivity were associated with higher ED prevalence. Analysis of TCPy modeled as a continuous variable revealed nonsignificant associations with ED (OR = 1.02 95% CI [0.95, 1.09]). Stratification of total TCPy into quartiles revealed increased odds of ED among adults in the second and fourth quartiles, using the first quartile as the reference (OR = 2.04 95% CI [1.11, 3.72], OR = 1.51 95% CI [0.58, 3.93], OR = 2.62 95% CI [1.18, 5.79], for quartiles 2, 3, and 4, respectively).

Conclusions

The results of our study suggest a potential role for chlorpyrifos and other OPs the pathogenesis of ED. Future studies are warranted to validate these findings, determine clinical significance, and to investigate potential mechanisms underlying these associations.
Literature
1.
go back to reference Huff RA, Corcoran JJ, Anderson JK, Abou-Donia MB (1994) Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum. J Pharmacol Exp Ther 269(1):329–335 (Epub 1994/04/01)PubMed Huff RA, Corcoran JJ, Anderson JK, Abou-Donia MB (1994) Chlorpyrifos oxon binds directly to muscarinic receptors and inhibits cAMP accumulation in rat striatum. J Pharmacol Exp Ther 269(1):329–335 (Epub 1994/04/01)PubMed
4.
go back to reference Solomon KR, Williams WM, Mackay D, Purdy J, Giddings JM, Giesy JP (2014) Properties and uses of chlorpyrifos in the United States. In: Giesy JP, Solomon KR (eds) Ecological risk assessment for chlorpyrifos in terrestrial and aquatic systems in the United States. Springer, Cham, pp 13–34CrossRef Solomon KR, Williams WM, Mackay D, Purdy J, Giddings JM, Giesy JP (2014) Properties and uses of chlorpyrifos in the United States. In: Giesy JP, Solomon KR (eds) Ecological risk assessment for chlorpyrifos in terrestrial and aquatic systems in the United States. Springer, Cham, pp 13–34CrossRef
5.
go back to reference Trunnelle KJ, Bennett DH, Tulve NS, Clifton MS, Davis MD, Calafat AM, Moran R, Tancredi DJ, Hertz-Picciotto I (2014) Urinary pyrethroid and chlorpyrifos metabolite concentrations in Northern California families and their relationship to indoor residential insecticide levels, part of the Study of Use of Products and Exposure Related Behavior (SUPERB). Environ Sci Technol 48(3):1931–1939. https://doi.org/10.1021/es403661a. (Epub 2014/01/16)ADSCrossRefPubMed Trunnelle KJ, Bennett DH, Tulve NS, Clifton MS, Davis MD, Calafat AM, Moran R, Tancredi DJ, Hertz-Picciotto I (2014) Urinary pyrethroid and chlorpyrifos metabolite concentrations in Northern California families and their relationship to indoor residential insecticide levels, part of the Study of Use of Products and Exposure Related Behavior (SUPERB). Environ Sci Technol 48(3):1931–1939. https://​doi.​org/​10.​1021/​es403661a. (Epub 2014/01/16)ADSCrossRefPubMed
13.
go back to reference Moon KH, Park SY, Kim YW (2019) Obesity and erectile dysfunction: from bench to clinical implication. World J Mens Health 37(2):138–147CrossRefPubMed Moon KH, Park SY, Kim YW (2019) Obesity and erectile dysfunction: from bench to clinical implication. World J Mens Health 37(2):138–147CrossRefPubMed
26.
go back to reference Feyzi Dehkhargani S, Malekinejad H, Shahrooz R, Sarkhanloo RA (2011) Detrimental effect of atrazine on testicular tissue and sperm quality: implication for oxidative stress and hormonal alterations. Iran J Toxicol 5(12):426–435 Feyzi Dehkhargani S, Malekinejad H, Shahrooz R, Sarkhanloo RA (2011) Detrimental effect of atrazine on testicular tissue and sperm quality: implication for oxidative stress and hormonal alterations. Iran J Toxicol 5(12):426–435
28.
31.
go back to reference National H, Nutrition Examination S (1997) NHANES III plan and operations procedures manuals CD-ROM: draft. National Centers for Disease Control and Prevention, Atlanta National H, Nutrition Examination S (1997) NHANES III plan and operations procedures manuals CD-ROM: draft. National Centers for Disease Control and Prevention, Atlanta
34.
go back to reference Barr DB, Bravo R, Weerasekera G, Caltabiano LM, Whitehead RD Jr, Olsson AO, Caudill SP, Schober SE, Pirkle JL, Sampson EJ, Jackson RJ, Needham LL (2004) Concentrations of dialkyl phosphate metabolites of organophosphorus pesticides in the U.S. population. Environ Health Perspect 112(2):186–200. https://doi.org/10.1289/ehp.6503. (Epub 2004/02/03)CrossRefPubMedPubMedCentral Barr DB, Bravo R, Weerasekera G, Caltabiano LM, Whitehead RD Jr, Olsson AO, Caudill SP, Schober SE, Pirkle JL, Sampson EJ, Jackson RJ, Needham LL (2004) Concentrations of dialkyl phosphate metabolites of organophosphorus pesticides in the U.S. population. Environ Health Perspect 112(2):186–200. https://​doi.​org/​10.​1289/​ehp.​6503. (Epub 2004/02/03)CrossRefPubMedPubMedCentral
Metadata
Title
Investigating the prevalence of erectile dysfunction among men exposed to organophosphate insecticides
Authors
F. Glover
A. Mehta
M. Richardson
W. Muncey
F. Del Giudice
F. Belladelli
N. Seranio
M. L. Eisenberg
Publication date
13-08-2023
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 2/2024
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-023-02155-8

Other articles of this Issue 2/2024

Journal of Endocrinological Investigation 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine